Erasca, Inc. saw its stock drop 48% after competitor Revolution Medicines challenged the intellectual property rights of Erasca's lead drug candidate, ERAS-0015. The dispute centers on claims that Erasca's drug infringes on RevMed's patents and misuses trade secrets, leading to demands to halt sales and misleading comparisons. This legal challenge wiped out over $2.8 billion in market value and prompted a shareholder rights investigation into whether Erasca misled investors about its patent protections. Investors facing losses are urged to seek legal advice as the situation develops.
Citytv has announced the renewal of its popular series Hudson & Rex for a new 12-episode season, with production beginning in June 2026 in St. John's, Newfoundland. John Reardon returns as detective Charlie Hudson, reuniting with his canine partner R...
Citytv has announced the renewal of its popular series Hudson & Rex for a new 12-episode season starting production in June 2026 in St. John's, Newfoundland. John Reardon returns as Detective Charlie Hudson, reuniting with his canine partner Rex, alo...
A NordLayer report reveals that 82% of IT professionals experienced web-based security incidents in the past year, with half describing the impact as moderate or severe. Increased use of BYOD policies, remote work, and SaaS tools expands attack surfa...
Medidata unveiled its next-generation AI-powered imaging solution at ASCO 2026, enhancing clinical trial efficiency by speeding up protected health information redaction by 32% and achieving over 97% accuracy in anatomy verification. This technology ...
CredFin, Inc. has partnered with The Agent Underground, led by Rob Thomas, to help independent insurance agents access capital for acquisitions and growth amid AI-driven industry disruption. With AI threatening traditional agent roles and acceleratin...
